LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.